Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03663621 · ClinicalTrials.gov registry record
Prepare - How to Reach Women of Reproductive Age With Obesity to Support Weight Loss Before Pregnancy?
A clinical trial, sponsored by Harvard Pilgrim Health Care.
- Completed
- Registry status
- 99
- Enrollment target
NCT03663621: Completed study, sponsored by Harvard Pilgrim Health Care.
NCT03663621 is a clinical trial that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03663621 has completed, sponsored by Harvard Pilgrim Health Care.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
Researchers at Harvard Pilgrim Health Care Institute and Massachusetts General Hospital are conducting a study to learn more about how best to reach out to women (age 18-45) who are thinking about a pregnancy in the next couple of years and currently have a BMI greater than 30 kg/m2. Interested participants will be asked to complete a 15-minute survey. The survey will ask some more questions about their prior reproductive health history, opinions and experiences regarding lifestyle, weight and health. After completing the survey, researchers would like to arrange a time to complete a 20- to 30-minute semi-structured interview about their perceived health in the process of planning pregnancy.
Primary Outcome
Feasibility determined by compiling the actual number of participants recruited divided by the time and resources necessary to achieve that number participants for each recruitment strategy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2018-01-25 |
| Est. Completion | 2020-06-15 |
What the finished NCT03663621 record still lists
NCT03663621 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03663621 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03663621 about?
NCT03663621 is a clinical study titled "Prepare - How to Reach Women of Reproductive Age With Obesity to Support Weight Loss Before Pregnancy?". Researchers at Harvard Pilgrim Health Care Institute and Massachusetts General Hospital are conducting a study to learn more about how best to reach out to women (age 18-45) who are thinking about a pregnancy in the next couple of years and currently have a BMI greater than 30 kg/m2. Interested par...
What is the current status of trial NCT03663621?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2018-01-25. Estimated completion is 2020-06-15.
Who is sponsoring clinical trial NCT03663621?
This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI